APA-viite

Soffietti, R., Pellerino, A., Pace, A., Carapella, C., Dealis, C., Caroli, M., . . . Rudà, R. (2017). ACTR-06. DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY. Neuro Oncol.

Chicago-tyylinen lähdeviittaus

Soffietti, Riccardo, Alessia Pellerino, Andrea Pace, Carmine Carapella, Cristina Dealis, Manuela Caroli, Marina Faedi, Lorenzo Bello, ja Roberta Rudà. "ACTR-06. DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY." Neuro Oncol 2017.

MLA-viite

Soffietti, Riccardo, et al. "ACTR-06. DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY." Neuro Oncol 2017.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.